This study compared serum immunological parameters, cytokines, intestinal permeability, fecal microbiota, and short-chain fatty acids (SCFAs) between healthy and diarrheic suckling calves. Serum and facecal samples were analyzed using ELISA kits, 16S rDNA sequencing, and targeted metabolomics. Compared with healthy calves, the serum levels of aspartate aminotransferase, interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), endotoxin (ET), and diamine oxidase (DAO) were significantly higher (p < 0.05), whereas the serum levels of immunoglobulin A (IgA), immunoglobulin G (IgG), and interleukin-10 (IL-10) were significantly lower in diarrheic calves (p < 0.05). The contents of propionic acid, butyric acid, and valeric acid significantly decreased in the fecal of diarrheic calves (p < 0.05). Moreover, the Chao1 and observed_features index of fecal microbiota significantly decreased in diarrheic calves (p < 0.05). The relative abundance of Escherichia-Shigella, Clostridium_sensu_stricto_1, and Streptococcus was significantly higher (p < 0.05), whereas Phascolarctobacterium, Ruminococcus torques group, and Faecalibacterium were significantly lower in diarrheic calves (p < 0.05). Escherichia-Shigella abundance was positively correlated with ET, DAO, IL-1β, and TNF-α levels (p < 0.05). Faecalibacterium abundance was significantly positively correlated with IgG, IgA, IL-10, and butyric acid but negatively correlated with ET and DAO levels (p < 0.05). In summary, diarrheic suckling calves exhibited reduced immune function, inflammatory response, and increased intestinal permeability. The relative abundance of fecal microbiota of Escherichia-Shigella and Clostridium_sensu_stricto_1 increased, while propionic acid, butyric acid, and valeric acid concentration were decreased in calves with diarrhea. This underscores the critical interplay between microbiota balance and gut health in diarrhea.

This study investigated the effects of dietary supplementation with varying doses of Clostridium butyricum (C. butyricum) on growth performance, diarrhea incidence, serum biochemical parameters, fecal short-chain fatty acids (SCFAs), and fecal microbiota in preweaning Holstein calves. Forty healthy newborn Holstein heifer calves with comparable birth weights were randomly assigned to four groups (control, 1 g/d supplementation, 3 g/d supplementation, and 5 g/d supplementation) for a 60-day trial. Growth parameters, diarrhea incidence, serum immunoglobulins (IgA, IgG, IgM), cytokines (IL-1β, TNF-α), antioxidant indicators (T-AOC, MDA), fecal short-chain fatty acids (SCFAs), and microbial composition were measured to evaluate the effects of C. butyricum. The results indicated that calves in the 5 g/d group exhibited a significantly higher average daily gain (ADG) compared with the control group (804.67 vs. 701.67 g/d, p < 0.05), with no significant differences in feed intake observed among groups (p > 0.05). During Days 22–42, the diarrhea incidence in the 5 g/d group was 7.74% lower than that in the control group (p < 0.05). This group exhibited significantly elevated serum IgM levels (Day 42, p < 0.05) and reduced IL-1β concentrations (Day 42, p < 0.05). Additionally, total antioxidant capacity (T-AOC) was significantly enhanced (Days 42 and 60, p < 0.05), while malondialdehyde (MDA) content was significantly decreased (Days 21 and 42, p < 0.05). At Day 42, fecal propionate and butyrate concentrations were significantly elevated in the 5 g/d group (p < 0.05), while the relative abundances of Bacteroides, Acidaminococcus, Bifidobacterium, Olsenella, Faecalitalea, and Ruminococcus were significantly increased (p < 0.05). The increase in these short-chain fatty acids and beneficial bacteria contributes to improved intestinal health and thus helps alleviate diarrhea. These findings indicate that supplementing preweaning calves’ milk with 5 g/d of C. butyricum significantly enhances growth performance and intestinal health. This provides evidence for the use of C. butyricum as a natural alternative to antibiotics in calf rearing.

This study aimed to investigate the effect of storage time on the fermentation quality, bacterial community structure, and metabolic profiles of Jinmu grain grass silage. It was ensiled in vacuum bags for 60 days. Samples were collected after 0, 3, 7, 15, 30, and 60 days of ensiling. Nutritional analysis revealed no significant differences in dry matter (DM), ether extract (EE), crude protein (CP), neutral detergent fiber (NDF), or acid detergent fiber (ADF) across storage periods (p > 0.05), but relative feeding value (RFV) significantly increased at 30 and 60 days (p < 0.05). Fermentation quality improved with prolonged storage, pH values declined to 4.01 at 60 days, while lactic acid (LA) and acetic acid (AA) increased significantly (p < 0.05). Butyric acid(BA) was undetected. 16S rDNA sequencing showed bacterial diversity (Chao1, Simpson, and Shannon indices) increased significantly at 30 and 60 days (p < 0.01); The relative abundance of Lacticaseibacillus, and Amylolactobacillus at 30 days were significantly higher than 0 and 60 days (p < 0.05); The relative abundance of Stenotrophomonas, Serratia, Comamonas, GKS98_freshwater_group, and Sphingobium at 60 days were significantly higher than 0 and 30 days (p < 0.05). Comprehensive targeted metabolomics identified 2958 metabolites. There were 256 differential metabolites shared by the comparison groups at 0, 30, and 60 days. The pathways for enrichment of differential metabolites mainly include plant hormone signal transduction, Histidine metabolism, arginine biosynthesis, etc. In conclusion, the storage time of Jinmu grain grass silage can enhance its fermentation quality by influencing microbial communities and metabolic pathways.

This study induced obesity in mice through a high-fat diet (HFD) to investigate the regulatory effects of Clostridium butyricum WL-53 (C. butyricum WL-53) on lipid metabolism and intestinal inflammation. Thirty 6-week-old male C57 mice were randomly divided into three groups: the normal diet group (ND), the high-fat diet group (HFD), and the HFD supplemented with Clostridium butyricum (CB, C. butyricum) group (HFD-CB). The experiment lasted for five weeks. The results demonstrated that mice in the HFD-CB group exhibited significantly alleviated weight gain, reduced fat mass, and decreased hepatic lipid deposition. C. butyricum WL-53 treatment improved serum and hepatic lipid markers (TC, TG), decreased the levels of pro-inflammatory factors (TNF-α, IL-1β), and increased those of anti-inflammatory factors (IL-10, IL-4). Gut microbiota analysis indicated that HFD reduced microbial diversity and increased the abundance of Firmicutes. Meanwhile, C. butyricum WL-53 intervention reversed these changes and enriched beneficial genera. Metabolomics analysis revealed that C. butyricum WL-53 regulated glycerophospholipid metabolism, arachidonic acid metabolism, and cAMP signaling pathways, reversing metabolites to ameliorate lipid deposition and inflammation. In summary, C. butyricum WL-53 alleviates HFD-induced obesity and inflammation via gut microbiota modulation and metabolic reprogramming.